{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:39:23Z","timestamp":1792154363765,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bbi.2020.04.013","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T10:54:12Z","timestamp":1586429652000},"page":"870-877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Chemokine alterations in bipolar disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"88","author":[{"given":"B\u0142a\u017cej","family":"Misiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Ma\u0142ecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Samochowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Jarosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Banik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Sta\u0144czykiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2020.04.013_b0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40345-019-0148-x","article-title":"Attenuated inflammatory response of monocyte-derived macrophage from patients with BD: a preliminary report","volume":"7","author":"Ascoli","year":"2019","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.bbi.2020.04.013_b0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2011.07.127","article-title":"CXCL8 protects human neurons from amyloid-\u03b2-induced neurotoxicity: relevance to Alzheimer\u2019s disease","volume":"412","author":"Ashutosh","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2020.04.013_b0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","article-title":"Comparison of inflammatory cytokine levels among type I\/type II and manic\/hypomanic\/euthymic\/depressive states of bipolar disorder","volume":"166","author":"Bai","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2020.04.013_b0020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/1381612053381684","article-title":"Blood-brain barrier transport of cytokines: a mechanism for neuropathology","volume":"11","author":"Banks","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbi.2020.04.013_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00406-012-0327-6","article-title":"Chemokines in bipolar disorder: trait or state?","volume":"263","author":"Barbosa","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.013_b0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00406-017-0817-7","article-title":"Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression","volume":"268","author":"Bartoli","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.013_b0035","doi-asserted-by":"crossref","first-page":"e986","DOI":"10.4088\/JCP.16m11310","article-title":"Higher baseline proinflammatory cytokines mark poor antidepressant response in bipolar disorder","volume":"78","author":"Benedetti","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/wps.20441","article-title":"Staging in bipolar disorder: from theoretical framework to clinical utility","volume":"16","author":"Berk","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1871530318666180131094733","article-title":"Relationship between proinflammatory cytokines\/chemokines and adipokines in serum of young adults with obesity","volume":"18","author":"Borges","year":"2018","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.bbi.2020.04.013_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.46","article-title":"Increased M1\/decreased M2 signature and signs of Th1\/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia","volume":"4","author":"Brambilla","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0055","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1586\/ern.10.185","article-title":"Insulin dysfunction and allostatic load in bipolar disorder","volume":"11","author":"Brietzke","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbi.2020.04.013_b0060","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbi.2009.04.008","article-title":"Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder","volume":"23","author":"Brietzke","year":"2009","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.013_b0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neubiorev.2017.03.003","article-title":"Acute variations of cytokine levels after antipsychotic treatment in drug-na\u00efve subjects with a first-episode psychosis: a meta-analysis","volume":"77","author":"Capuzzi","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2020.04.013_b0070","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.bbi.2011.03.013","article-title":"The activation of monocyte and T cell networks in patients with bipolar disorder","volume":"25","author":"Drexhage","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.013_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2016.02.006","article-title":"A meta-analysis of chemokines in major depression","volume":"68","author":"Eyre","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2015.08.036","article-title":"Peripheral inflammation during abnormal mood states in bipolar i disorder","volume":"187","author":"Fiedorowicz","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2020.04.013_b0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pbb.2018.12.006","article-title":"Revisiting inflammation in bipolar disorder","volume":"177","author":"Fries","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2020.04.013_b0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2018.05.002","article-title":"Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study","volume":"71","author":"Frydecka","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.013_b0095","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jclinepi.2010.08.010","article-title":"Conducting quantitative synthesis when comparing medical interventions: AHRQ and the effective health care program","volume":"64","author":"Fu","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bbi.2020.04.013_b0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/wps.20631","article-title":"Transdiagnostic psychiatry: a systematic review","volume":"18","author":"Fusar-Poli","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41380-019-0448-7","article-title":"Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review","volume":"25","author":"Giridharan","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0110","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins","year":"2011"},{"key":"10.1016\/j.bbi.2020.04.013_b0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Method"},{"key":"10.1016\/j.bbi.2020.04.013_b0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbi.2014.10.001","article-title":"Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment","volume":"43","author":"Isgren","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.013_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2016.03.040","article-title":"Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar i disorder \u2013 results from a prospective study","volume":"197","author":"Jacoby","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2020.04.013_b0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1503\/jpn.140183","article-title":"Monocyte and microglial activation in patients with mood-stabilized bipolar disorder","volume":"40","author":"Jakobsson","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbi.2020.04.013_b0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bmt.1705872","article-title":"How lithium treatment generates neutrophilia by enhancing phosphorylation of GSK-3, increasing HIF-1 levels and how this path is important during engraftment","volume":"41","author":"Kast","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbi.2020.04.013_b0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant\u2019Anna","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2020.04.013_b0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtemb.2007.03.001","article-title":"Lithium down-regulates the expression of CXCR4 in human neutrophils","volume":"21","author":"Kim","year":"2007","journal-title":"J. Trace Elem. Med Biol."},{"key":"10.1016\/j.bbi.2020.04.013_b0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2020.04.013_b0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/mp.2017.205","article-title":"Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis","volume":"23","author":"Leighton","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0160","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jcp.25604","article-title":"Valproic acid and lithium meditate anti-inflammatory effects by differentially modulating dendritic cell differentiation and function","volume":"232","author":"Leu","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbi.2020.04.013_b0165","article-title":"High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder","volume":"98","author":"Lu","year":"2019","journal-title":"Med. (United States)"},{"key":"10.1016\/j.bbi.2020.04.013_b0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0175","first-page":"1","article-title":"Role of CXCL10 in central nervous system inflammation","volume":"2014","author":"Michlmayr","year":"2014","journal-title":"Int. J. Interf. Cytokine Mediat. Res."},{"key":"10.1016\/j.bbi.2020.04.013_b0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fpsyt.2019.00005","article-title":"Editorial: peripheral markers of immune response in major psychiatric disorders: where are we now and where do we want to be?","volume":"10","author":"Misiak","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2017.04.015","article-title":"Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review","volume":"192","author":"Misiak","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2020.04.013_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbi.2020.04.013_b0195","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2020.04.013_b0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2020.04.013_b0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O\u2019Brien","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2020.04.013_b0210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/acps.12791","article-title":"Infectious and immunogenetic factors in bipolar disorder","volume":"136","author":"Oliveira","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2020.04.013_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","author":"Osimo","year":"2020","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.013_b0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jad.2014.12.010","article-title":"Increased serum levels of eotaxin\/CCL11 in late-stage patients with bipolar disorder: an accelerated aging biomarker?","volume":"182","author":"Panizzutti","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2020.04.013_b0225","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/mp.2016.130","article-title":"Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity","volume":"22","author":"Pantazatos","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b9000","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.euroneuro.2017.04.001","article-title":"Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation","volume":"27","author":"Pariante","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2020.04.013_b0230","first-page":"37","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Poeta","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2020.04.013_b0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pscychresns.2019.01.009","article-title":"Markers of neuroinflammation influence measures of cortical thickness in bipolar depression","volume":"285","author":"Poletti","year":"2019","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.bbi.2020.04.013_b0240","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.2018.144","article-title":"Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses","volume":"213","author":"Rowland","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0245","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpsychires.2017.03.018","article-title":"A systemic review of evidence for the role of inflammatory biomarkers in bipolar patients","volume":"92","author":"Sayana","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2020.04.013_b0250","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/ijerph15051033","article-title":"Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review","volume":"15","author":"Strzelak","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bbi.2020.04.013_b0255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neubiorev.2014.02.001","article-title":"Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies","volume":"42","author":"Stuart","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2020.04.013_b0260","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fncel.2015.00357","article-title":"Systematic review of the neurobiological relevance of chemokines to psychiatric disorders","volume":"9","author":"Stuart","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.013_b0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fpsyt.2018.00241","article-title":"Revisiting the role of eotaxin-1\/CCL11 in psychiatric disorders","volume":"9","author":"Teixeira","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","article-title":"Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides","volume":"42","author":"Torres-Platas","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.013_b0275","article-title":"Chemokines: key molecules that orchestrate communication among neurons, microglia and astrocytes to preserve brain function","author":"Trettel","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2020.04.013_b0280","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw012","article-title":"The differential levels of inflammatory cytokines and bdnf among bipolar spectrum disorders","volume":"19","author":"Wang","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2020.04.013_b0285","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers \u2013 a meta-analysis","volume":"80","author":"Wi\u0119d\u0142ocha","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.013_b0290","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fncel.2014.00154","article-title":"Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers","volume":"8","author":"Williams","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.013_b0295","article-title":"Significantly higher prevalence rate of asthma and bipolar disorder co-morbidity: a meta-analysis and review under PRISMA guidelines","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine (United States)"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120300957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120300957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:15:01Z","timestamp":1760170501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159120300957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":60,"alternative-id":["S0889159120300957"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.04.013","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine alterations in bipolar disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}